November 20, 2019 / 8:48 AM / 16 days ago

BRIEF-Celon Pharma Obtains European Patent For PI3K Kinase Inhibitor and Applications

Nov 20 (Reuters) - Celon Pharma SA:

* SAID ON TUESDAY IT HAS OBTAINED A EUROPEAN PATENT FOR PI3K KINASE INHIBITOR

* PATENT ALSO INCLUDES APPLICATION OF SAID INHIBITOR IN TREATMENT OF IMMUNE-MEDIATED AND INFLAMMATORY DISEASES AS WELL AS ONCOLOGICAL THERAPIES

* DEVELOPMENT OF SAID INHIBITOR IN PATIENTS WITH LUNG DISEASES IS TAKING PLACE THROUGH COMPANY’S “PIKCEL” PROJECT WHICH IS CURRENTLY IN PRECLINICAL TEST PHASE

* COMPANY IS ALSO EXPLORING THE APPLICATION OF SAID INHIBITOR WITHIN THE OBTAINED PATENT IN AREAS OUTSIDE OF “PIKCEL” PROJECT

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below